Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_03640
Species: Homo sapiens
Position : chr21:43772291-43774291
Year: 2014
Title: Establishment of active chromatin structure at enhancer elements by mixed-lineage leukemia 1 to initiate estrogen-dependent gene expression.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: Mixed-Lineage Leukemia 1
PMID:  24288367
Tissue: blood / hematopoietic system
Tissue Ontology ID: UBERON:0000178
Cell Source: MCF-7
CVCL ID: CVCL_0031
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: TF-binding/chromatin assay; In vivo functional validation; Disease-associated enhancer analysis
Low Throughput Method: ChIP-qPCR/ChIP; RT-qPCR/qPCR
About Target Gene
Target gene : TFF1
About TF
TF name : KMT2A
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
KMT2A PKMTs methylate histone lysines reactome 64
KMT2A Hs_Senescence_and_Autophagy_in_Cancer_WP615_81193 wikipathways 62
Enhancer Associated Network
Overlapping Enhancers (hg19) 8 found
Enhancer ID Position Tissue Cell Disease
E_04616 chr21:43770915-43772915 breast malignant cell breast cancer
E_04633 chr21:43770915-43772915 breast NA NA
E_04634 chr21:43770915-43772915 breast NA NA
E_03643 chr21:43771491-43773491 blood / hematopoietic system malignant cell Mixed-Lineage Leukemia 1
E_03644 chr21:43771491-43773491 blood / hematopoietic system malignant cell Mixed-Lineage Leukemia 1
E_03645 chr21:43771491-43773491 blood / hematopoietic system malignant cell Mixed-Lineage Leukemia 1
E_03641 chr21:43772291-43774291 blood / hematopoietic system malignant cell Mixed-Lineage Leukemia 1
E_03642 chr21:43772291-43774291 blood / hematopoietic system malignant cell Mixed-Lineage Leukemia 1
Expression of Target Genes for the Enhancer